ANDA 71478, held by Perrigo New York. Betamethasone Valerate.
As of Nov 15, 2026, ANDA 71478 (Betamethasone Valerate), held by Perrigo New York, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Betamethasone ValerateEQ 0.1% BASE ยท ointment;topical | Betamethasone Valerate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
